COSMETICS APPLICATION

04.C07

Active Encapsulation
engineered with chitosan.

Chitosan particles and matrices for protecting cosmetic actives and controlling how they are delivered.

Scientist preparing encapsulated cosmetic-active samples
ACTIVE ENCAPSULATION · PROTECTION + DELIVERY
FORMULATION + SAMPLE PROGRAMCOSMETICS

01 · THE CUSTOMER PROBLEM

Sensitive oils, fragrances and cosmetic actives can lose stability or deliver too quickly when added directly to a formulation.

Chitosan particles and matrices can protect selected actives, change their release and increase residence at the target surface.

Chitosan particles and matrices for protecting cosmetic actives and controlling how they are delivered.

02 · RECOMMENDED STARTING POINT

Start with the material designed for the decision.

MYKITO PLATFORMBioFoundry
RECOMMENDED SAMPLEAn encapsulation feasibility screen built around the customer's selected active.

The polymer's charge, modifiable backbone and ability to form particles make it a versatile carrier for selected oils, fragrances and functional actives.

01

Without the shell

Controlled fungal sourcing supports a traceable, non-animal supply strategy.

02

Specification engineered

MW, DDA, purity, charge density and format are selected around the target result.

03

Application ready

Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.

04

One technical partner

Material selection, formulation support and the validation plan are connected from the first sample.

03 · PERFORMANCE TARGETS

Build toward outcomes a buyer can measure.

01

Active protection

Active protection can be developed by matching the chitosan specification, dose and application-ready format to the finished active encapsulation system.

02

Controlled release

Controlled release can be developed by matching the chitosan specification, dose and application-ready format to the finished active encapsulation system.

03

Surface-targeted delivery

Surface-targeted delivery can be developed by matching the chitosan specification, dose and application-ready format to the finished active encapsulation system.

04 · GO / NO-GO CRITERIA

Define the evidence before testing begins.

The first program is designed around three decision-making outputs—not an open-ended material trial.

01

Encapsulation efficiency and loading

02

Particle size and formulation stability

03

Release profile and retained active performance

Encapsulation efficiencyParticle sizeStabilityRelease profileFormulation compatibility

05 · FROM SAMPLE TO DECISION

A practical application program,
not a bag of powder.

01

Define

Agree on the function, baseline, constraints and measurable success criteria.

02

Screen

Select the MW, DDA, purity, dose and physical format that fit the application.

03

Validate

Test the winning system in the finished formulation, device, process or use environment.

AVAILABLE FORMATS
NanoparticlesMicrocapsulesHydrogel matrix

Recommended first request: An encapsulation feasibility screen built around the customer's selected active.

Start the Sample Brief

06 · WHY CHITOSAN

Deposition + hydrated film formation

Cationic charge and interfacial adhesion can increase surface residence, while continuous polymer films support moisture management and active carrying.

FORMULATION WINDOW

There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.

QUALIFICATION

Appearance, sensory, stability, preservation and performance are validated in the finished cosmetic formula.

START A FORMULATION PROGRAM

Move from material potential
to a defined program.

Tell us what performance, purity and format your application needs. We will help identify the right Mykito platform and a practical next step.